The international annual partnering meeting is targeted at R&D and CMC professionals, service providers and Investment Managers,nand provides an opportunity to meet, network and discuss best practices related to outsourcing in drug development. It will cover all stages from preclinical research to late clinical phases, preclinical and clinical bioanalysis as well as contract manufacturing and regulatory issues, contract research and manufacturing in both small molecule and biological APIs. The meeting will include pre-bookable face-to-face-meetings and will be covered by the media
Info: Life Science Sweden, Maria Eriksson
